Challenges of personalised oncology

Implementing precision medicine in cancer care

Clinical validity of NGS and innovation in clinical diagnosis

Serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ cell tumour patients

Latest in adjuvant therapy for renal cell carcinoma

Hypoxia related mRNA biomarker to predict biochemical failure and metastasis for prostate cancer

Pseudo-invasive lesions of the breast

Management of inflammatory breast cancer

Recommendation guidelines in breast cancer resolution for the Eastern Mediterranean

The FIGO toolbox and risk stratification of endometrial cancer

Screening for the fallopian tube as the origin of ovarian cancer

The DESKTOPIII trial in platinum-sensitive ovarian cancer